Tata Chemicals Ltd
NSE: TATACHEM BSE: 500770
Incorporated in 1939, Tata Chemicals Ltd manufactures and exports basic chemistry and specialty products [1]
₹730
52W: ₹580 — ₹1027
PE 30 · Book ₹758 · -4% vs bookMarket Cap₹18,595 Cr
Stock P/E30Price to Earnings
ROCE4.18%Return on Capital
ROE3.3%Return on Equity
Div. Yield1.53%Face Value ₹10
Strengths
- +Stock is trading at 0.96 times its book value
- +Company has been maintaining a healthy dividend payout of 46.4%
Weaknesses
- −The company has delivered a poor sales growth of 10.0% over past five years.
- −Tax rate seems low
- −Company has a low return on equity of 3.51% over last 3 years.
- −Earnings include an other income of Rs.365 Cr.
Shareholding Pattern
Promoters37.98%
FIIs11.9%
DIIs22.83%
Public27.25%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 37.98% | 37.98% | 37.98% | 37.98% | 37.98% | 37.98% | 37.98% | 37.98% |
| FIIs | 13.76% | 13.56%▼0.2 | 13.6%▲0.0 | 13.29%▼0.3 | 12.85%▼0.4 | 13.73%▲0.9 | 12.26%▼1.5 | 11.9%▼0.4 |
| DIIs | 19.91% | 20.34%▲0.4 | 21.68%▲1.3 | 21.96%▲0.3 | 22.61%▲0.6 | 22.17%▼0.4 | 22.4%▲0.2 | 22.83%▲0.4 |
| Public | 28.31% | 28.08%▼0.2 | 26.72%▼1.4 | 26.73%▲0.0 | 26.53%▼0.2 | 26.07%▼0.5 | 27.34%▲1.3 | 27.25%▼0.1 |
Financial Statements
| Metric | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,093 | 1,090 | 1,047 | 1,009 | 1,166 | 1,219 | 1,169 | 1,204 | 1,204 | 1,254 |
| Expenses | 887 | 898 | 812 | 865 | 957 | 989 | 899 | 964 | 976 | 1,038 |
| Operating Profit | 206 | 192 | 235 | 144 | 209 | 230 | 270 | 240 | 228 | 216 |
| OPM % | 19% | 18% | 22% | 14% | 18% | 19% | 23% | 20% | 19% | 17% |
| Net Profit | 115 | 217 | 271 | 99 | 72 | 115 | 307 | 178 | 73 | 48 |
| EPS ₹ | 4.51 | 8.52 | 10.64 | 3.89 | 2.83 | 4.51 | 12.05 | 6.99 | 2.86 | 1.88 |
AI Insights
Revenue Trend
Mar 2026 revenue at ₹4,831Cr, up 8.8% YoY. OPM at 20%.
Debt Position
Borrowings at ₹3,487Cr. Debt-to-equity ratio: 0.18x. Healthy balance sheet.
Capex Cycle
CWIP at ₹473Cr (9% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 22.83% (+2.92pp change). FIIs: 11.9% (-2.57pp change). Promoters hold 37.98%.
Margin & Efficiency
ROCE declining from 12% (Mar 2015) to 4% (Mar 2026). Working capital days: 34.
Valuation
PE 30x with 4.18% ROCE. Price is -4% above book value of ₹758. Dividend yield: 1.53%.
Recent Announcements
- Communication To Shareholders - Intimation On Tax Deduction On Dividend 2d - Board recommended ₹11 dividend per share for FY26; AGM on June 26, 2026, TDS details due June 8.
- Announcement under Regulation 30 (LODR)-Date of payment of Dividend 14 May - 87th AGM on June 26, 2026; record date June 10 for ₹11 dividend.
- Intimation Of Record Date For Payment Of Dividend 14 May - 87th AGM on June 26, 2026; ₹11 dividend record date set for June 10, 2026.
- Intimation Of Date Of 87Th Annual General Meeting 14 May - 87th AGM on June 26, 2026; record date June 10, 2026; dividend ₹11 per share recommended.
- Announcement under Regulation 30 (LODR)-Earnings Call Transcript 9 May - Transcript of Analysts/investors call pertaining to the Financial Results for the Quarter and Financial year ended March 31, 2026
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse